|
|||||
|
|
| 我国丙型肝炎防治新策略探讨 | |
| 引用本文： | 窦晓光,丁洋. 我国丙型肝炎防治新策略探讨[J]. 传染病信息, 2016, 0(2). DOI: 10.3969/j.issn.1007-8134.2016.02.002 |
| 作者姓名： | 窦晓光 丁洋 |
| 作者单位： | 中国医科大学附属盛京医院感染科, 沈阳,110022 |
| 基金项目： | 国家"十二五"科技重大专项(2012ZX10002003),辽宁省传染性疾病转化医学研究中心建设(2014225020) |
| 摘 要： | 随着新型高效口服直接抗病毒药物在欧美国家临床上的广泛应用,不但提高了慢性丙型肝炎(丙肝)及肝硬化的临床治愈率,也使我们对丙肝的认识和治疗理念发生了根本性改变。从控制病毒到治愈丙肝,从治疗疾病到以治为防,从应答指导的个体化治疗策略到全口服、泛基因型、短疗程的全覆盖方案。面对这种新的治疗形式,我国现阶段的丙肝防治新策略更值得关注。 |
| 关 键 词： | 丙型肝炎 治疗学 抗病毒药 |
New strategies for prevention and treatment of hepatitis C in China |
|
| DOU Xiao-guang,DING Yang. New strategies for prevention and treatment of hepatitis C in China[J]. Infectious Disease Information, 2016, 0(2). DOI: 10.3969/j.issn.1007-8134.2016.02.002 | |
| Authors: | DOU Xiao-guang DING Yang |
| Abstract: | With clinical application of efficient oral direct-acting antiviral agents in European and Ammerican countries, patients with chronic hepatitis C or liver cirrhosis may achieve high sustained virological response, and meanwhile our understanding of hepatitis C and its treatment has been changed fundamentally from the control of the virus to the cure of hepatitis C, from clinical care to prevention of hepatitis C by treatment, from response-guided therapy to all-oral, all-genotype and short-course treatment. Facing the new treatment situation, much attention needs to be given to current new prevention and control strategies for hepatitis C in China. |
| Keywords: | hepatitis C therapeutics antiviral agents |
| 本文献已被 CNKI 万方数据 等数据库收录！ | |